Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
GKSL

Gujarat Kidney and Super Speciality Share Price

 

 

Gujarat Kidney and Super Speciality live price: ₹142.08. It opened at ₹144 vs previous close ₹142; intraday high/low: ₹147/₹139. The 50 DMA stands at ₹117.05.

Gujarat Kidney and Super Speciality Performance

  • Today's Low
  • ₹139
  • Today's High
  • ₹147
  • 52 Week Low
  • ₹98
  • 52 Week High
  • ₹148
  • Open Price₹144
  • Previous Close₹142
  • Volume1,708,553
  • 50 DMA₹117.05
  • 100 DMA-
  • 200 DMA-

Gujarat Kidney and Super Speciality Chart

Investment Returns

  • Over 1 Month + 33.65%
  • Over 3 Month + 28.63%
  • Over 6 Month + 24.63%
  • Over 1 Year + 24.63%

Smart Investing Starts Here Start SIP with Gujarat Kidney and Super Speciality for Steady Growth!

Invest Now

Gujarat Kidney and Super Speciality Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 1,120
  • P/B Ratio
  • 31.8
  • Average True Range
  • 6.47
  • EPS
  • 1.49
  • Dividend Yield
  • 0
  • MACD Signal
  • 6.44
  • RSI
  • 80.81
  • MFI
  • 85.15

Gujarat Kidney and Super Speciality Financials

Gujarat Kidney and Super Speciality Technicals

EMA & SMA

Current Price
₹142.08
+ 0.51 (0.36%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 11
  • 20 Day
  • ₹126.61
  • 50 Day
  • ₹117.05
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

142.71 Pivot Speed
  • R3 154.33
  • R2 150.67
  • R1 146.37
  • S1 138.41
  • S2 134.75
  • S3 130.45

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Gujarat Superspeciality Hospital is a multi-speciality hospital in Vadodara with ICU beds, ICU on wheels, modular operation theatres, diagnostics, dialysis, and trauma care. It offers advanced surgical and medical treatments across multiple specialties.

Gujarat Kidney & Super Speciality Ltd has an operating revenue of Rs. 91.68 Cr. on a trailing 12-month basis. ROE of 15% is good. The stock from a technical standpoint is comfortably placed above its key moving averages, around 26% and 29% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 15% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 43 which is a POOR score indicating inconsistency in earnings, a RS Rating of 89 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 72 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Gujarat Kidney and Super Speciality Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-14 Quarterly Results (Revised)

Gujarat Kidney and Super Speciality Shareholding Pattern

71.45%
0%
0%
4.89%
0%
10.64%
13.02%

Gujarat Kidney and Super Speciality FAQs

Gujarat Kidney and Super Speciality share price is ₹142 As on 14 May, 2026 | 18:00

The Market Cap of Gujarat Kidney and Super Speciality is ₹1120.2 Cr As on 14 May, 2026 | 18:00

The P/E ratio of Gujarat Kidney and Super Speciality is As on 14 May, 2026 | 18:00

The PB ratio of Gujarat Kidney and Super Speciality is 31.8 As on 14 May, 2026 | 18:00

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23